肱骨干骨折手术与非手术治疗的患者报告结局比较:斯堪的纳维亚肱骨干骨折试验(SHAFT)——一项实用性随机对照试验的研究方案
SHAFT试验为实用性多中心随机对照试验,分SHAFT-Young与SHAFT-Elderly两组,计划纳入287例急性肱骨干骨折,随机分配至手术或非手术治疗,允许延迟愈合时早期交叉。主要结局为52周时手臂、肩和手功能障碍(DASH)评分,采用评估者盲法。
要点
- 计划纳入287例急性肱骨干骨折,随机分配至手术或非手术治疗。
- 主要结局为52周时DASH评分,评估者盲法。
- 允许因延迟愈合而早期交叉至手术。
核心结论
- SHAFT试验将比较肱骨干骨折手术与非手术治疗的患者报告结局,并考虑人群差异及早期交叉手术的困境。
研究设计与样本
- 实用性多中心随机对照试验,设SHAFT-Young和SHAFT-Elderly两个研究组。
- 计划招募287例 eligible 急性肱骨干骨折并随机分配至手术或非手术治疗。
- 手术方式由外科医生在分配范围内决定。
- 主要结局为52周时DASH评分,采用评估者盲法。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局:52周时DASH评分。
- 次要结局:DASH评分、EQ-5D-5L、视觉模拟评分法疼痛评分、Constant-Murley评分(含肘关节活动度)及锚定问题,在所有时间点收集。
- 报告所有并发症:感染、神经或血管损伤、手术翻修(植入物位置不当、硬件失败、无菌性松动、假体周围骨折)、主要不良心血管事件及死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The outcome of non-surgical treatment is generally good, but the treatment course can be long and painful with approximately a quarter of the patients acquiring a nonunion. Both surgical and non-surgical treatment can have disabling consequences such as nerve injury, infection, and nonunion. The purpose of the study is to compare patient-reported outcomes after surgical and non-surgical treatment for humeral shaft fractures. METHODS: A pragmatic randomized controlled trial (RCT) is planned with two study groups (SHAFT-Young and SHAFT-Elderly). A total of 287 eligible acute humeral shaft fractures are scheduled to be recruited and randomly allocated to surgical or non-surgical treatment with the option of early crossover due to delayed union. The surgical method within the allocation is decided by the surgeon. The primary outcome is the Disability of Arm, Shoulder, and Hand (DASH) score at 52 weeks, and is assessor blinded. The secondary outcomes are DASH score, EQ-5D-5L, pain assessed by visual analog score, Constant-Murley score including elbow range of motion, and anchor questions collected at all timepoints throughout the trial. All complications will be reported including; infection, nerve or vascular injury, surgical revisions (implant malpositioning, hardware failure, aseptic loosening, and peri-implant fracture), major adverse cardiovascular events, and mortality. DISCUSSION: The SHAFT trial is a pragmatic multicenter RCT, that will compare the effectiveness of the main strategies in humeral shaft fracture treatment. This will include a variety of fracture morphologies, while taking the dilemmas within the population into account by splitting the population by age and providing the orthopedic society with an interval for early crossover surgery. TRIAL REGISTRATION: Clinicaltrials.gov NCT04574336 . Registered on 5 October 2020.
引用
- Karimi D, Brorson S, Midtgaard KS, et al. Surgical versus non-surgical treatment of humeral SHAFT fractures compared by a patient-reported outcome: the Scandinavian Humeral diAphyseal Fracture Trial (SHAFT)-a study protocol for a pragmatic randomized controlled trial. Trials. 2022. PMID: 35655280. doi:10.1186/s13063-022-06317-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。